{"gene":"SOX5","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":1994,"finding":"Sox5 protein localizes to the nucleus of post-meiotic round spermatids in mouse testis and binds specifically to the sequence AACAAT with moderately high affinity (Kd ~10^-9 M), inducing a significant bend in the DNA characteristic of HMG box proteins.","method":"Indirect immunofluorescence, in vitro footprinting, gel retardation assays, circular dichroism spectroscopy, 2D NMR","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal in vitro biochemical methods (footprinting, EMSA, CD, NMR) in a single study","pmids":["8078768"],"is_preprint":false},{"year":1998,"finding":"L-Sox5 (long form of Sox5) contains a coiled-coil domain that mediates homodimerization and heterodimerization with Sox6; dimerization greatly increases efficiency of binding to DNA containing adjacent HMG sites. L-Sox5, Sox6, and Sox9 cooperatively activate Col2a1 expression through a 48 bp chondrocyte-specific enhancer containing HMG-like sites.","method":"Coiled-coil domain analysis, dimerization assays, DNA binding assays, reporter assays in 10T1/2 and MC615 cells, co-expression studies in mouse embryos","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution of cooperative DNA binding, functional enhancer validation, replicated across multiple systems","pmids":["9755172"],"is_preprint":false},{"year":1998,"finding":"The Sox5 HMG box from mouse undergoes two-stage reversible unfolding corresponding to two structural sub-domains (minor wing: helix 3 + N-terminal strand; major wing: helices I and II), with the minor wing considerably unfolded at physiological temperature (37°C).","method":"Differential scanning calorimetry, fluorescence spectroscopy, NMR","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — calorimetric and NMR structural characterization, rigorous biophysical methods","pmids":["9710541"],"is_preprint":false},{"year":1999,"finding":"The Sox5 HMG box binds its AACAAT target DNA with an association constant of ~4×10^7 M^-1 (ΔG = −40 to −48 kJ/mol), with binding thermodynamics characteristic of minor groove HMG box proteins including a large negative heat capacity change (~−2 kJ/K/mol) reflecting dehydration of the protein-DNA interface.","method":"Fluorescence titration, isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC)","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — rigorous quantitative thermodynamic characterization with multiple complementary methods","pmids":["10588902"],"is_preprint":false},{"year":2001,"finding":"Sox5 (L-Sox5) and Sox6 are required for formation of cartilage in mouse embryos; double-null mutants (Sox5−/−/Sox6−/−) show severe skeletal malformations with failure of chondroblast differentiation, establishing Sox5 and Sox6 as redundant transcriptional regulators of chondrogenesis.","method":"Genetic knockout mouse models, in vivo skeletal analysis","journal":"Osteoarthritis and cartilage","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with defined cellular phenotype, replicated across labs","pmids":["11680692"],"is_preprint":false},{"year":2001,"finding":"NMR solution structure of the mouse Sox5 HMG box in free solution reveals a characteristic twisted L-shape with two wings (major wing: helices 1 and 2; minor wing: helix 3 with N-terminal segment), with significant backbone mobility in the minor wing that increases toward termini.","method":"Multidimensional NMR with 15N-labeled protein, 15N relaxation measurements","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 — NMR structure determination with backbone dynamics characterization","pmids":["11266597"],"is_preprint":false},{"year":2002,"finding":"Sox9 is required upstream of Sox5 and Sox6 in chondrogenesis; conditional inactivation of Sox9 before mesenchymal condensations abolishes Sox5 and Sox6 expression, placing Sox9 upstream of Sox5/Sox6 in the chondrogenic transcriptional hierarchy.","method":"Cre/loxP conditional knockout in mouse embryos, in situ hybridization for Sox5/Sox6 expression","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis established by conditional KO with specific marker expression readout","pmids":["12414734"],"is_preprint":false},{"year":2003,"finding":"Sox5 and Sox6 are required in the notochord for formation of the extracellular matrix sheath, notochord cell survival, and development of the nucleus pulposus; Sox5−/−/Sox6−/− mice lack notochord ECM sheath and downregulate Col2a1, aggrecan, and perlecan in notochord cells.","method":"Genetic double-knockout mouse model, in situ hybridization, immunohistochemistry, apoptosis assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific molecular and cellular phenotype readouts","pmids":["12571105"],"is_preprint":false},{"year":2004,"finding":"The combination of SOX5, SOX6, and SOX9 (the SOX trio) is sufficient to induce chondrocyte differentiation in non-chondrogenic cell types including dermal fibroblasts, suppressing hypertrophic and osteogenic differentiation simultaneously.","method":"Embryonic stem cell reporter assay, primary mesenchymal stem cell differentiation, marker gene expression, proteoglycan matrix accumulation","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function in multiple cell types with molecular marker validation","pmids":["15529345"],"is_preprint":false},{"year":2007,"finding":"Sox5 and Sox6, together with Sox9 and coactivators CBP/p300, activate transcription of the COMP (cartilage oligomeric matrix protein) gene; Sox9 binds directly to a 13-nucleotide element in the COMP promoter PRE, and Sox5/Sox6 cooperate with Sox9 and CBP/p300 for full activation.","method":"Reporter assays, gel shift assays, siRNA knockdown, EMSA","journal":"Frontiers in bioscience","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct binding and reporter assays, single lab","pmids":["17485346"],"is_preprint":false},{"year":2008,"finding":"L-Sox5 and Sox6 drive aggrecan (Agc1) gene expression by binding to three elements in a far-upstream enhancer, which cooperatively increases the efficiency of Sox9 binding to its own recognition site within the same enhancer, thereby potentiating Sox9-driven transcription.","method":"Transgenic mouse reporter assays, ChIP, EMSA, mutational analysis of enhancer elements","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding demonstrated, transgenic validation in vivo, mechanistic mutational analysis","pmids":["18559420"],"is_preprint":false},{"year":2008,"finding":"The coactivator Tip60 physically associates with Sox9 and Sox5 (identified by yeast two-hybrid and confirmed by co-IP), and the Sox9-Tip60-DNA complex assembles on the Col2a1 enhancer; Tip60 enhances Sox9 transcriptional activity and acetylates Sox9 at K61, K253, and K398 residues.","method":"Yeast two-hybrid, Co-IP, gel shift assay, reporter assay, ChIP, subnuclear colocalization, siRNA knockdown in micromass cultures","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (yeast 2-hybrid, reciprocal Co-IP, ChIP, reporter assay, in vitro functional validation)","pmids":["18390577"],"is_preprint":false},{"year":2008,"finding":"Sox5 modulates Sox10 activity in the melanocyte lineage by binding to regulatory regions of melanocytic Sox10 target genes and recruiting corepressors CtBP2 and HDAC1, directly inhibiting Sox10-dependent promoter activation; Sox5 loss partially rescues the melanoblast reduction in Sox10 heterozygous mice.","method":"Genetic mouse models (Sox5 KO, Sox10 het crosses), ChIP showing Sox5 recruitment of CtBP2 and HDAC1, reporter assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis, ChIP, reporter assays with mechanistic corepressor identification","pmids":["18703590"],"is_preprint":false},{"year":2010,"finding":"S-SOX5 (48-kDa short isoform) directly binds to and activates the SPAG6 (sperm-associated antigen 6) promoter via SOX5 binding sites, cooperating with FOXJ1 to stimulate SPAG6 expression; mutation of SOX5 binding sites abrogates promoter activation.","method":"Luciferase reporter assay with SOX5 binding site mutations, ChIP, EMSA, siRNA knockdown, SOX5 overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding shown by EMSA and ChIP, causal link by site mutagenesis and RNAi","pmids":["20668334"],"is_preprint":false},{"year":2010,"finding":"SOX5 overexpression in chick neural progenitors causes premature cell cycle exit, while SOX5 knockdown extends the proliferative period and causes cell death in a dorsal interneuron population; SOX5 reduces WNT-beta-catenin signaling by triggering expression of the negative regulator Axin2.","method":"In ovo overexpression and knockdown, cell cycle analysis, reporter assay for WNT pathway activity","journal":"EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function with pathway readout, but single model system","pmids":["20448664"],"is_preprint":false},{"year":2010,"finding":"Sox5 and Sox6 are required for proper synovial joint morphogenesis; complete Sox5/Sox6 double KO prevents joint interzone formation and cavitation, while chondrocyte-specific inactivation (Col2Cre) also blocks joint morphogenesis, establishing that Sox5/Sox6 chondrogenic function is essential for joint development.","method":"Complete and cell-type-specific conditional knockout using Cre/loxP (Sox5fl/fl6fl/fl with Col2Cre and Gdf5Cre drivers), histology, marker gene expression","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with multiple Cre drivers, specific cellular and molecular phenotypes","pmids":["20206616"],"is_preprint":false},{"year":2010,"finding":"L-Sox5/Sox6 and Nfib proteins bind to conserved proximal elements in the Matn1 (matrilin-1) promoter and modulate Sox9 transactivation in a protein dose-dependent manner to restrict expression to specific growth plate zones.","method":"Transgenic mouse reporter assays, EMSA, mutational analysis, protein binding assays","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding and transgenic validation, mechanistic detail on cooperativity","pmids":["21173167"],"is_preprint":false},{"year":2011,"finding":"SOX5 and SOX6 physically interact with SHOX (short stature homeobox gene) via the SHOX homeodomain and SOX6 HMG domain (confirmed by yeast two-hybrid and co-immunoprecipitation in human cells), and this interaction is required for cooperative activation of the aggrecan (Agc1) upstream enhancer; LWD-causing SHOX missense mutations disrupt this interaction.","method":"Yeast two-hybrid screen, Co-IP in human cells, immunohistochemistry in human fetal growth plates, reporter assays, domain mapping","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, domain mapping, functional validation with disease-causing mutations","pmids":["21262861"],"is_preprint":false},{"year":2011,"finding":"Sox5 knockout mice exhibit abnormal lung development with a delay in maturation before the saccular stage (as early as E16.5) associated with decreased fibronectin expression, an ECM component critical for branching morphogenesis.","method":"Sox5−/− mouse histology and gene expression analysis","journal":"American journal of respiratory and critical care medicine","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with specific molecular readout, single lab","pmids":["21330457"],"is_preprint":false},{"year":2012,"finding":"L-Sox5 and Sox6 enhance Sox9 homodimer-driven transcription of miR-140 by binding to an L-Sox5/Sox6/Sox9 response element in the pri-miR-140 proximal promoter, boosting Sox9's DNA-binding and/or transactivation ability as a homodimer.","method":"Reporter assays in vivo and in vitro, ChIP, DNA binding analysis with genetically modified mice","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding and functional assays with genetic mouse models, single lab","pmids":["22547066"],"is_preprint":false},{"year":2014,"finding":"Sox5 (novel Th17-specific isoform Sox5t) physically associates with c-Maf via the HMG domain of Sox5 and the DNA-binding domain of c-Maf; Sox5 and c-Maf cooperatively and directly activate the RORγt promoter in CD4+ T cells, acting as downstream targets of Stat3 and upstream inducers of RORγt to drive Th17 differentiation.","method":"Co-immunoprecipitation (domain mapping), ChIP on RORγt promoter, retroviral overexpression in Stat3-deficient and RORγt-deficient cells, T cell-specific Sox5 KO mice with EAE model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — physical interaction with domain mapping, ChIP, genetic epistasis using multiple KO backgrounds, in vivo disease model","pmids":["25073789"],"is_preprint":false},{"year":2014,"finding":"Sox5 directly transactivates Twist1 expression in breast cancer cells by binding to the Twist1 promoter (shown by ChIP); Sox5 depletion downregulates Twist1, reduces EMT markers (N-cadherin, Vimentin, Fibronectin 1), and upregulates E-cadherin.","method":"ChIP assay, luciferase reporter, siRNA knockdown, Western blot","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP and reporter assay establish direct binding, single lab","pmids":["24607904"],"is_preprint":false},{"year":2014,"finding":"Sox5 functions as a DNA-binding cofactor for BMP R-Smads (Smad1/4) in Xenopus ectoderm; Sox5 physically interacts with BMP R-Smads and is essential for recruitment of Smad1/4 to BMP regulatory elements, thereby activating BMP target genes required for neural crest and epidermal patterning.","method":"Xenopus embryo overexpression/knockdown, Co-IP of Sox5 with BMP R-Smads, ChIP showing Smad1/4 recruitment to BMP regulatory elements, target gene expression analysis","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1-2 — physical interaction demonstrated, ChIP shows recruitment to regulatory elements, genetic loss-of-function with specific patterning phenotype","pmids":["25453832"],"is_preprint":false},{"year":2015,"finding":"SOX9 and SOX5/SOX6 bind thousands of genomic sites genome-wide in chondrocytes, frequently co-occupying super-enhancers (SEs); SOX9 recognizes pairs of inverted SOX motifs while SOX6 favors pairs of tandem SOX motifs; together they co-activate nearly all cartilage-specific SEs to drive the chondrocyte differentiation program.","method":"Genome-wide ChIP-seq for SOX6 and SOX9 in RCS cells, motif analysis, SE analysis, in vivo validation of target gene expression","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide ChIP-seq with motif analysis, functional validation of target genes in vivo","pmids":["26150426"],"is_preprint":false},{"year":2015,"finding":"Sox5 and Sox6 transcription factors directly promote oligodendrocyte progenitor migration by activating PDGFRα expression, thereby maintaining responsiveness to PDGF-A as a migratory cue; they also cooperate with Sox9 and Sox10 to activate PDGFRα expression, in contrast to their antagonism of SoxE proteins on myelin genes.","method":"CNS-specific conditional Sox5/Sox6 double KO mice, migration assays, marker gene expression, functional rescue","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with specific cellular and molecular phenotype, single lab","pmids":["26345464"],"is_preprint":false},{"year":2016,"finding":"SOX5 directly binds and activates the RANKL promoter in IL-6-stimulated rheumatoid synovial fibroblasts; ChIP shows ~3-fold enrichment of RANKL-specific DNA in anti-SOX5 immunoprecipitate after IL-6 treatment; knockdown of SOX5 reduces IL-6-mediated RANKL upregulation and bone erosion in CIA mice.","method":"ChIP, overexpression/knockdown studies, in vivo CIA mouse model with local SOX5 silencing, immunohistochemistry","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP demonstrates direct promoter binding, in vivo functional validation","pmids":["27550416"],"is_preprint":false},{"year":2017,"finding":"Sox5 promotes EMT and prostate cancer metastasis as a master regulator of TGF-β-induced EMT; Smad3 binds to the Sox5 promoter and regulates its expression, and Sox5 in turn binds to the Twist1 promoter to activate Twist1, which initiates EMT.","method":"ChIP, luciferase reporter assay, siRNA knockdown, xenograft mouse model, Western blot","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP for direct promoter binding, epistasis defined by pathway, in vivo validation","pmids":["29123266"],"is_preprint":false},{"year":2017,"finding":"SOX5 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by directly binding to and activating the MMP-9 promoter; ChIP confirms SOX5 binding to MMP-9 promoter and deletion of the SOX5 binding site abolishes promoter-driven transcription; SOX5 knockdown reduces MMP-9 expression and pannus invasion in CIA mice.","method":"ChIP, luciferase reporter with SOX5 binding site deletion, transwell assay, in vivo CIA mouse model","journal":"Frontiers in immunology","confidence":"High","confidence_rationale":"Tier 2 — ChIP + site-specific deletion mutant + in vivo validation, multiple orthogonal approaches","pmids":["29706965"],"is_preprint":false},{"year":2017,"finding":"Sox5 regulates beta-cell phenotype and insulin secretion; Sox5 knockdown reduces depolarization-evoked Ca2+-influx and β-cell exocytosis, while SOX5 overexpression reverses expression perturbations in a T2D mouse model and improves glucose-stimulated insulin secretion in human islets.","method":"Sox5 knockdown/overexpression in pancreatic islets, Ca2+ imaging, patch-clamp exocytosis measurements, gene expression profiling","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — loss- and gain-of-function with specific electrophysiological and secretion readouts, validated in human islets","pmids":["28585545"],"is_preprint":false},{"year":2017,"finding":"Sox5 can suppress PDGFB-induced glioma development in Ink4a-deficient cells by increasing p27(Kip1) levels and inducing cellular senescence; Sox5 overexpression reduces Akt activation and increases p27(Kip1), and inhibition of p27(Kip1) reverses Sox5-mediated effects on proliferation and senescence.","method":"Retroviral overexpression of Sox5 in primary brain cell cultures, glioma mouse model, Western blot for Akt and p27(Kip1), p27 inhibition rescue experiments","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function with pathway dissection and rescue experiment, single lab","pmids":["19219070"],"is_preprint":false},{"year":2017,"finding":"SOX5, SOX6, and SOX21 prevent oncogene-driven transformation of brain stem cells; elevated SOX5/6/21 promotes cell cycle exit upon oncogenic stress and prevents glioma-like tumor formation; restoring SOX5/6/21 in glioblastoma cells enables CDK inhibitor expression, decreases p53 protein turnover, and triggers cellular senescence and apoptosis.","method":"Genetic ablation (Sox5/6/21 triple KO), in vivo mouse brain tumor model, overexpression in human glioblastoma cells, cell cycle analysis","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with tumor phenotype, mechanistic molecular readouts","pmids":["28687615"],"is_preprint":false},{"year":2018,"finding":"SOX5 promotes breast cancer proliferation and invasion by directly binding to and transactivating the EZH2 promoter; ChIP-seq and quantitative ChIP confirm SOX5 binding, and the biological effect of SOX5 is dependent on EZH2 expression.","method":"ChIP-seq, quantitative ChIP, luciferase reporter assay, gain/loss-of-function studies with MTT, colony formation, invasion assays","journal":"Oncology letters","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq and reporter assay, rescue experiment demonstrates EZH2 dependence","pmids":["30854049"],"is_preprint":false},{"year":2018,"finding":"SOX5 interacts with YAP1 as a protein complex in NSCLC cells to drive malignant potential; SOX5 is preferentially expressed by cancer stem-like cells, and silencing YAP1 attenuates malignant processes consistent with SOX5 loss; SOX5 overexpression reverses YAP1 knockdown-mediated effects.","method":"Co-immunoprecipitation, gain/loss-of-function studies, xenograft model","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP, functional epistasis by rescue experiment","pmids":["29888108"],"is_preprint":false},{"year":2019,"finding":"SOX5 directly activates the GLUT4 promoter and is regulated by the VEGFR2/AKT1/GSK3β signaling pathway in ovarian cancer cells; SOX5 overexpression rescues GLUT4 expression and glycolysis suppressed by apatinib.","method":"Dual-luciferase reporter assay for GLUT4 promoter, RNA-seq, Western blot, xenograft model","journal":"Cellular oncology","confidence":"Medium","confidence_rationale":"Tier 2-3 — reporter assay for direct promoter activation, pathway validation by rescue","pmids":["31325096"],"is_preprint":false},{"year":2019,"finding":"FOX-A1 directly binds to the SOX5 promoter and transactivates SOX5 expression in lung adenocarcinoma, as demonstrated by ChIP-seq and ChIP assays; SOX5 is a downstream target of FOX-A1 driving EMT and chemoresistance.","method":"ChIP-seq, ChIP assay, qRT-PCR, Western blot, knockdown studies","journal":"EBioMedicine","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq identifies direct promoter occupancy, functional validation","pmids":["31147293"],"is_preprint":false},{"year":2019,"finding":"SOX5 induces angiogenesis in lung adenocarcinoma by activating STAT3 phosphorylation and increasing VEGF expression; SOX5 overexpression promotes tube formation capacity of endothelial cells, and this is dependent on STAT3/VEGF signaling.","method":"Tube formation assay, lentiviral overexpression/knockdown, qRT-PCR, Western blot, tissue microarray","journal":"OncoTargets and therapy","confidence":"Low","confidence_rationale":"Tier 3 — functional assay without direct promoter binding evidence for VEGF","pmids":["30254466"],"is_preprint":false},{"year":2020,"finding":"Brachyury directly binds to two motifs in the SOX5 promoter (one canonical and one novel Bry-binding motif) and activates SOX5 transcription; SOX5 is a direct downstream target of Brachyury and mediates Brachyury-driven EMT and breast cancer bone metastasis.","method":"ChIP assay, luciferase reporter assay with binding motif identification, in vitro and in vivo metastasis assays","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP and reporter assay with novel motif identification, single lab","pmids":["31713604"],"is_preprint":false},{"year":2020,"finding":"SOX5 transcriptionally activates VEGF expression to promote neuroprotection; SOX5 overexpression rescues LPS-induced apoptosis in PC-12 cells via VEGF-dependent PI3K/AKT pathway activation, as confirmed by ChIP-PCR and dual luciferase reporter assay.","method":"ChIP-PCR, dual luciferase reporter assay, Western blot, TUNEL assay, CCK-8 assay","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 3 — single ChIP and reporter assay, single cell model, single lab","pmids":["32949698"],"is_preprint":false},{"year":2021,"finding":"SOX5 activates a novel RORγt enhancer (RORCE2) in Th17 cells by binding to its SOX5 binding site, which enables RORCE2 looping to the RORγt promoter and recruitment of STAT3 to the RORγt locus; RORCE2 deficiency suppresses RORγt expression and Th17 differentiation.","method":"CRISPR knockout of RORCE2, chromatin conformation capture (3C/looping assay), ChIP showing SOX5 and STAT3 binding, Th17 differentiation assays, EAE mouse model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — CRISPR KO of enhancer, 3D chromatin looping, ChIP, in vivo disease model — multiple orthogonal methods","pmids":["33473108"],"is_preprint":false},{"year":2021,"finding":"TNF-α upregulates SOX5 expression in human bone marrow mesenchymal stem cells, and SOX5 inhibits osteogenic differentiation through the KLF4 signaling pathway; SOX5 overexpression increases KLF4 expression, and KLF4 knockdown abrogates the inhibitory effect of SOX5 on osteogenesis.","method":"Overexpression/knockdown (RNA interference), ALP activity assay, RT-qPCR, Western blot, epistasis by KLF4 knockdown rescue","journal":"Molecules and cells","confidence":"Medium","confidence_rationale":"Tier 2-3 — epistasis established by double knockdown rescue, single lab","pmids":["29890823"],"is_preprint":false},{"year":2023,"finding":"SOX5 overexpression acts as a driver of cellular rejuvenation by binding to and elevating enhancer activity (H3K27ac and H3K4me1) of HMGB2, increasing HMGB2 expression; SOX5 gene therapy rejuvenates cartilage and alleviates osteoarthritis in aged mice.","method":"Genome-wide CRISPRa screening, epigenomic profiling (H3K27ac, H3K4me1 ChIP), SOX5 binding analysis, lentiviral gene therapy in aged mice","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — genome-wide unbiased screen plus epigenomic validation of enhancer mechanism, in vivo validation","pmids":["37832549"],"is_preprint":false}],"current_model":"SOX5 is a SRY-related HMG box transcription factor that functions primarily as a DNA-binding cofactor and transcriptional modulator: in chondrogenesis, L-Sox5 homodimerizes or heterodimerizes with Sox6 via a coiled-coil domain to cooperatively bind paired HMG sites on cartilage-specific enhancers (Col2a1, Agc1, COMP, Matn1, miR-140), potentiating Sox9-driven transcription genome-wide through super-enhancers; in immunity, a Th17-specific Sox5 isoform physically interacts with c-Maf and directly activates the RORγt promoter/enhancer downstream of STAT3 to drive Th17 differentiation; in cancer contexts, Sox5 directly transactivates Twist1, MMP-9, EZH2, RANKL, and VEGF promoters to promote EMT and invasion; and in neural and other lineages, Sox5 modulates SoxE protein (Sox9, Sox10) activity by competing for binding sites and recruiting corepressors (CtBP2, HDAC1), thereby acting as either a coactivator or repressor depending on cellular context."},"narrative":{"teleology":[{"year":1994,"claim":"Establishing the DNA-binding specificity and structural mode of Sox5: its HMG box binds the minor groove of AACAAT with nanomolar affinity and induces DNA bending, defining Sox5 as a canonical HMG-box transcription factor.","evidence":"In vitro footprinting, EMSA, CD, and 2D NMR on purified mouse Sox5 HMG box","pmids":["8078768"],"confidence":"High","gaps":["Full-length protein binding properties unknown","No cellular target genes identified","In vivo relevance of AACAAT binding not tested"]},{"year":1998,"claim":"Revealing how L-Sox5 achieves cooperative enhancer occupancy: its coiled-coil domain mediates homo- and heterodimerization with Sox6, enabling efficient binding to paired HMG sites and cooperative activation of the Col2a1 chondrocyte enhancer with Sox9.","evidence":"Dimerization assays, DNA-binding assays, and reporter assays in 10T1/2 and MC615 cells; biophysical characterization of HMG box unfolding by DSC and NMR","pmids":["9755172","9710541"],"confidence":"High","gaps":["Genome-wide binding landscape unknown","Structural basis of the Sox5–Sox6 coiled-coil interface unresolved","Whether dimerization is required in vivo not tested"]},{"year":2001,"claim":"Genetic proof that Sox5 and Sox6 are essential, largely redundant regulators of chondrogenesis: double-null mice show catastrophic failure of chondroblast differentiation and skeletal formation, while single knockouts are viable.","evidence":"Sox5−/−/Sox6−/− double-knockout mouse embryos with in vivo skeletal analysis; NMR solution structure of free Sox5 HMG box confirmed L-shaped fold","pmids":["11680692","11266597"],"confidence":"High","gaps":["Downstream transcriptional targets not identified genome-wide","Relative contribution of each gene in specific skeletal elements unclear","Whether Sox5 has Sox6-independent roles not addressed"]},{"year":2002,"claim":"Establishing the transcriptional hierarchy: Sox9 is required upstream of Sox5/Sox6 expression, meaning Sox5/Sox6 act as Sox9-induced cofactors rather than independent initiators of chondrogenesis.","evidence":"Conditional Sox9 inactivation before mesenchymal condensation abolishes Sox5/Sox6 expression (Cre/loxP, in situ hybridization)","pmids":["12414734"],"confidence":"High","gaps":["Whether Sox9 directly activates Sox5 transcription or acts indirectly unknown","Feedback from Sox5/Sox6 onto Sox9 not tested"]},{"year":2003,"claim":"Expanding Sox5/Sox6 function beyond cartilage: they are essential for notochord ECM sheath formation and nucleus pulposus development, with double knockouts lacking expression of Col2a1, aggrecan, and perlecan in notochord cells.","evidence":"Sox5−/−/Sox6−/− mice analyzed by in situ hybridization, immunohistochemistry, and apoptosis assays in notochord","pmids":["12571105"],"confidence":"High","gaps":["Mechanism of notochord cell death (apoptosis vs. anoikis) unclear","Direct promoter occupancy in notochord not demonstrated"]},{"year":2008,"claim":"Defining the enhancer-level mechanism: L-Sox5/Sox6 bind specific elements in the Agc1 far-upstream enhancer to cooperatively increase Sox9 binding efficiency, and Sox5 recruits the corepressors CtBP2 and HDAC1 on Sox10 target genes in melanocytes, establishing Sox5 as a dual-function cofactor (coactivator or corepressor depending on context).","evidence":"ChIP, EMSA, transgenic reporter assays for Agc1 enhancer; genetic epistasis (Sox5 KO × Sox10 het), ChIP for CtBP2/HDAC1 recruitment, and reporter assays for melanocyte genes; Tip60 interaction with Sox5/Sox9 on Col2a1 enhancer by yeast two-hybrid and Co-IP","pmids":["18559420","18703590","18390577"],"confidence":"High","gaps":["Structural basis for cofactor switching unknown","Whether CtBP2/HDAC1 recruitment occurs genome-wide or at select loci not determined","How Sox5 discriminates between coactivator and corepressor modes unresolved"]},{"year":2010,"claim":"Broadening Sox5 roles to sperm motility, neural development, and joint morphogenesis: S-Sox5 directly activates the SPAG6 promoter; Sox5 modulates WNT-β-catenin signaling in neural progenitors to control cell cycle exit; and Sox5/Sox6 are required for synovial joint interzone formation.","evidence":"ChIP/EMSA/site mutagenesis for SPAG6 promoter; in ovo overexpression/knockdown with WNT reporter in chick; Col2Cre and Gdf5Cre conditional double-KO mice for joint phenotype","pmids":["20668334","20448664","20206616"],"confidence":"High","gaps":["Whether S-Sox5 has distinct target repertoire from L-Sox5 is unknown","Direct Sox5 targets in neural progenitors not identified","How Sox5/Sox6 regulate interzone specification molecularly unclear"]},{"year":2014,"claim":"Identifying Sox5 as a key immune transcription factor: a Th17-specific isoform (Sox5t) interacts with c-Maf via the HMG domain and cooperatively activates the RORγt promoter downstream of STAT3, establishing Sox5 as essential for Th17 differentiation and autoimmune pathology.","evidence":"Co-IP with domain mapping, ChIP on RORγt promoter, T cell-specific Sox5 KO mice in EAE model, epistasis with Stat3-deficient and RORγt-deficient cells","pmids":["25073789"],"confidence":"High","gaps":["Genome-wide Sox5t targets in Th17 cells unknown","Whether Sox5t has unique structural features vs. L-Sox5 not determined","Role in human Th17-driven diseases not directly demonstrated"]},{"year":2014,"claim":"Sox5 acts as a cofactor for BMP R-Smads: it physically interacts with Smad1/4 and is required for their recruitment to BMP regulatory elements, activating BMP target genes for neural crest and epidermal patterning in Xenopus.","evidence":"Co-IP of Sox5 with BMP R-Smads, ChIP for Smad1/4 at BMP response elements, loss-of-function patterning phenotype in Xenopus embryos","pmids":["25453832"],"confidence":"High","gaps":["Conservation of Sox5–Smad interaction in mammals not tested","Whether this applies to all BMP targets or a subset unclear"]},{"year":2015,"claim":"Genome-wide mapping reveals SOX9 and SOX5/SOX6 co-occupy thousands of sites including nearly all cartilage super-enhancers, with SOX6 preferring tandem SOX motifs and SOX9 inverted motifs, defining the chromatin logic of chondrocyte identity.","evidence":"ChIP-seq for SOX6 and SOX9 in RCS cells, motif enrichment analysis, super-enhancer identification","pmids":["26150426"],"confidence":"High","gaps":["SOX5-specific ChIP-seq not performed (SOX6 used as proxy)","3D chromatin architecture at these super-enhancers not mapped in chondrocytes","Functional hierarchy among co-occupied enhancers unclear"]},{"year":2017,"claim":"Multiple studies establish Sox5 as a direct transcriptional activator in cancer and metabolic contexts: Sox5 binds the Twist1 promoter to drive EMT in breast and prostate cancer, activates MMP-9 in rheumatoid synoviocytes, and maintains β-cell identity and insulin secretion.","evidence":"ChIP and reporter assays for Twist1 and MMP-9 promoters; Sox5 knockdown/overexpression in pancreatic islets with Ca2+ imaging and exocytosis measurements; xenograft and CIA mouse models","pmids":["24607904","29123266","29706965","28585545"],"confidence":"Medium","gaps":["Direct Sox5 targets in β-cells not mapped genome-wide","Whether EMT-driving function is isoform-specific unknown","Mechanism of Sox5-mediated insulin exocytosis regulation unclear"]},{"year":2021,"claim":"The 3D chromatin mechanism of Sox5 in Th17 cells is elucidated: Sox5 binds a novel RORγt enhancer (RORCE2) to enable its looping to the RORγt promoter and STAT3 recruitment; CRISPR deletion of RORCE2 suppresses Th17 differentiation and ameliorates EAE.","evidence":"CRISPR knockout of RORCE2, 3C/chromatin looping assays, ChIP for SOX5 and STAT3, EAE model","pmids":["33473108"],"confidence":"High","gaps":["Whether Sox5 establishes or maintains the loop is unknown","Other Sox5-dependent enhancer loops in Th17 cells not identified","RORCE2 conservation across species not established"]},{"year":2023,"claim":"SOX5 is identified as a driver of cellular rejuvenation: it binds and activates the HMGB2 enhancer (increasing H3K27ac and H3K4me1), and SOX5 gene therapy rejuvenates aged cartilage and alleviates osteoarthritis in mice.","evidence":"Genome-wide CRISPRa screen, epigenomic profiling (H3K27ac/H3K4me1 ChIP), SOX5 binding analysis, lentiviral gene therapy in aged mice","pmids":["37832549"],"confidence":"High","gaps":["Whether SOX5-mediated rejuvenation extends beyond cartilage unknown","Mechanism by which HMGB2 mediates rejuvenation incompletely defined","Long-term safety and durability of SOX5 gene therapy not assessed"]},{"year":null,"claim":"Key unresolved questions include: the structural basis for Sox5 isoform-specific partner selection (Sox6/c-Maf/Smad1/YAP1), the genome-wide Sox5 (as opposed to Sox6) cistrome in chondrocytes and Th17 cells, and how Sox5 switches between coactivator and corepressor modes across lineages.","evidence":"","pmids":[],"confidence":"Low","gaps":["No Sox5-specific ChIP-seq in primary chondrocytes","Structural model of Sox5 coiled-coil dimer interface lacking","Mechanism governing coactivator-to-corepressor switch unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,3,10,13,23]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,10,12,13,20,21,27,31,38,40]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,11]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,10,13,20,21,23,27,31,38,40]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,6,7,8,15,22,24]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[20,38]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[14,22,29]}],"complexes":["L-Sox5/Sox6 homodimer/heterodimer","Sox5/Sox6/Sox9 chondrogenic trio"],"partners":["SOX6","SOX9","MAF","CTBP2","HDAC1","KAT5","SMAD1","YAP1"],"other_free_text":[]},"mechanistic_narrative":"SOX5 is an SRY-related HMG-box transcription factor that functions as a context-dependent transcriptional cofactor across chondrogenesis, immune differentiation, neural development, and cancer. In cartilage, the long isoform (L-Sox5) homodimerizes or heterodimerizes with Sox6 via a coiled-coil domain, binding paired HMG sites on enhancers of cartilage matrix genes (Col2a1, Agc1, COMP, Matn1, miR-140) to potentiate Sox9-driven transcription at super-enhancers genome-wide; Sox5/Sox6 double-knockout mice exhibit severe chondrodysplasia, failed joint morphogenesis, and notochord defects [PMID:9755172, PMID:18559420, PMID:26150426, PMID:11680692, PMID:12571105]. In Th17 cells, a lineage-specific isoform (Sox5t) physically interacts with c-Maf and activates a distal RORγt enhancer (RORCE2), enabling STAT3 recruitment and chromatin looping to the RORγt promoter to drive Th17 differentiation [PMID:25073789, PMID:33473108]. SOX5 can also repress SoxE-dependent transcription by recruiting CtBP2 and HDAC1 corepressors, as demonstrated in the melanocyte lineage where it inhibits Sox10 target genes, and it functions as a direct transcriptional activator of Twist1, EZH2, MMP-9, and VEGF in cancer contexts to promote epithelial–mesenchymal transition, invasion, and angiogenesis [PMID:18703590, PMID:24607904, PMID:30854049, PMID:29706965]."},"prefetch_data":{"uniprot":{"accession":"P35711","full_name":"Transcription factor SOX-5","aliases":[],"length_aa":763,"mass_kda":84.0,"function":"Transcription factor involved in chondrocytes differentiation and cartilage formation. Specifically binds the 5'-AACAAT-3' DNA motif present in enhancers and super-enhancers and promotes expression of genes important for chondrogenesis, including cartilage matrix protein-coding genes, such as COL2A1 and AGC1. Required for overt chondrogenesis when condensed prechondrocytes differentiate into early stage chondrocytes: SOX5 and SOX6 cooperatively bind with SOX9 on active enhancers and super-enhancers associated with cartilage-specific genes, and thereby potentiate SOX9's ability to transactivate. Not involved in precartilaginous condensation, the first step in chondrogenesis, during which skeletal progenitors differentiate into prechondrocytes. Together with SOX6, required to form and maintain a pool of highly proliferating chondroblasts between epiphyses and metaphyses, to form columnar chondroblasts, delay chondrocyte prehypertrophy but promote hypertrophy, and to delay terminal differentiation of chondrocytes on contact with ossification fronts. Binds to the proximal promoter region of the myelin protein MPZ gene","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P35711/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SOX5","classification":"Not Classified","n_dependent_lines":17,"n_total_lines":1208,"dependency_fraction":0.014072847682119206},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SOX5","total_profiled":1310},"omim":[{"mim_id":"616803","title":"LAMB-SHAFFER SYNDROME; LAMSHF","url":"https://www.omim.org/entry/616803"},{"mim_id":"611502","title":"CENTROMERIC PROTEIN K; CENPK","url":"https://www.omim.org/entry/611502"},{"mim_id":"609860","title":"DAD1-RELATED GENE","url":"https://www.omim.org/entry/609860"},{"mim_id":"609858","title":"ETHANOLAMINE KINASE 1; ETNK1","url":"https://www.omim.org/entry/609858"},{"mim_id":"608160","title":"SRY-BOX 9; SOX9","url":"https://www.omim.org/entry/608160"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"testis","ntpm":29.2}],"url":"https://www.proteinatlas.org/search/SOX5"},"hgnc":{"alias_symbol":["L-SOX5","MGC35153"],"prev_symbol":[]},"alphafold":{"accession":"P35711","domains":[{"cath_id":"1.10.30.10","chopping":"557-626","consensus_level":"medium","plddt":96.5187,"start":557,"end":626},{"cath_id":"1.20.5","chopping":"627-660","consensus_level":"medium","plddt":82.595,"start":627,"end":660}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35711","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35711-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35711-F1-predicted_aligned_error_v6.png","plddt_mean":57.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SOX5","jax_strain_url":"https://www.jax.org/strain/search?query=SOX5"},"sequence":{"accession":"P35711","fasta_url":"https://rest.uniprot.org/uniprotkb/P35711.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35711/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35711"}},"corpus_meta":[{"pmid":"12414734","id":"PMC_12414734","title":"The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12414734","citation_count":1404,"is_preprint":false},{"pmid":"9755172","id":"PMC_9755172","title":"A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9755172","citation_count":662,"is_preprint":false},{"pmid":"11680692","id":"PMC_11680692","title":"L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway.","date":"2001","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/11680692","citation_count":294,"is_preprint":false},{"pmid":"15529345","id":"PMC_15529345","title":"The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage.","date":"2004","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/15529345","citation_count":279,"is_preprint":false},{"pmid":"18559420","id":"PMC_18559420","title":"L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18559420","citation_count":245,"is_preprint":false},{"pmid":"26150426","id":"PMC_26150426","title":"The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26150426","citation_count":223,"is_preprint":false},{"pmid":"19521496","id":"PMC_19521496","title":"Copy number variation in intron 1 of SOX5 causes the Pea-comb phenotype in chickens.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19521496","citation_count":179,"is_preprint":false},{"pmid":"12571105","id":"PMC_12571105","title":"Sox5 and Sox6 are required for notochord extracellular matrix sheath formation, notochord cell survival and development of the nucleus pulposus of intervertebral discs.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12571105","citation_count":136,"is_preprint":false},{"pmid":"19647094","id":"PMC_19647094","title":"The SoxD transcription factors--Sox5, Sox6, and Sox13--are key cell fate modulators.","date":"2009","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19647094","citation_count":135,"is_preprint":false},{"pmid":"25305447","id":"PMC_25305447","title":"MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5.","date":"2014","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/25305447","citation_count":131,"is_preprint":false},{"pmid":"8078769","id":"PMC_8078769","title":"DNA binding and bending properties of the post-meiotically expressed Sry-related protein Sox-5.","date":"1994","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8078769","citation_count":108,"is_preprint":false},{"pmid":"25073789","id":"PMC_25073789","title":"Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25073789","citation_count":107,"is_preprint":false},{"pmid":"22290657","id":"PMC_22290657","title":"Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features.","date":"2012","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/22290657","citation_count":92,"is_preprint":false},{"pmid":"22396742","id":"PMC_22396742","title":"MiR-194 regulates chondrogenic differentiation of human adipose-derived stem cells by targeting Sox5.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22396742","citation_count":80,"is_preprint":false},{"pmid":"18703590","id":"PMC_18703590","title":"The transcription factor Sox5 modulates Sox10 function during melanocyte development.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18703590","citation_count":78,"is_preprint":false},{"pmid":"8812465","id":"PMC_8812465","title":"Cloning and characterization of SOX5, a new member of the human SOX gene family.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8812465","citation_count":75,"is_preprint":false},{"pmid":"10588902","id":"PMC_10588902","title":"The energetics of HMG box interactions with DNA: thermodynamics of the DNA binding of the HMG box from mouse sox-5.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10588902","citation_count":74,"is_preprint":false},{"pmid":"30983072","id":"PMC_30983072","title":"Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/30983072","citation_count":71,"is_preprint":false},{"pmid":"18390577","id":"PMC_18390577","title":"Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18390577","citation_count":71,"is_preprint":false},{"pmid":"18852073","id":"PMC_18852073","title":"Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume.","date":"2008","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/18852073","citation_count":70,"is_preprint":false},{"pmid":"22547066","id":"PMC_22547066","title":"L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22547066","citation_count":69,"is_preprint":false},{"pmid":"29123266","id":"PMC_29123266","title":"Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.","date":"2017","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29123266","citation_count":65,"is_preprint":false},{"pmid":"11585348","id":"PMC_11585348","title":"Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing.","date":"2001","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/11585348","citation_count":64,"is_preprint":false},{"pmid":"21333351","id":"PMC_21333351","title":"Chondrogenesis of human mesenchymal stem cells mediated by the combination of SOX trio SOX5, 6, and 9 genes complexed with PEI-modified PLGA nanoparticles.","date":"2011","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/21333351","citation_count":63,"is_preprint":false},{"pmid":"21421267","id":"PMC_21421267","title":"Chondrogenesis of adipose stem cells in a porous PLGA scaffold impregnated with plasmid DNA containing SOX trio (SOX-5,-6 and -9) genes.","date":"2011","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/21421267","citation_count":63,"is_preprint":false},{"pmid":"21330457","id":"PMC_21330457","title":"SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development.","date":"2011","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21330457","citation_count":58,"is_preprint":false},{"pmid":"20206616","id":"PMC_20206616","title":"Synovial joint morphogenesis requires the chondrogenic action of Sox5 and Sox6 in growth plate and articular cartilage.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20206616","citation_count":57,"is_preprint":false},{"pmid":"20448664","id":"PMC_20448664","title":"SOX5 controls cell cycle progression in neural progenitors by interfering with the WNT-beta-catenin pathway.","date":"2010","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/20448664","citation_count":56,"is_preprint":false},{"pmid":"11912161","id":"PMC_11912161","title":"Coamplification of DAD-R, SOX5, and EKI1 in human testicular seminomas, with specific overexpression of DAD-R, correlates with reduced levels of apoptosis and earlier clinical manifestation.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11912161","citation_count":56,"is_preprint":false},{"pmid":"26345464","id":"PMC_26345464","title":"Transcription factors Sox5 and Sox6 exert direct and indirect influences on oligodendroglial migration in spinal cord and forebrain.","date":"2015","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/26345464","citation_count":55,"is_preprint":false},{"pmid":"28632999","id":"PMC_28632999","title":"Long noncoding RNA lnc-sox5 modulates CRC tumorigenesis by unbalancing tumor microenvironment.","date":"2017","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/28632999","citation_count":54,"is_preprint":false},{"pmid":"29499929","id":"PMC_29499929","title":"Inhibition of TDP43-Mediated SNHG12-miR-195-SOX5 Feedback Loop Impeded Malignant Biological Behaviors of Glioma Cells.","date":"2017","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/29499929","citation_count":54,"is_preprint":false},{"pmid":"29378592","id":"PMC_29378592","title":"Sox5 is involved in germ-cell regulation and sex determination in medaka following co-option of nested transposable elements.","date":"2018","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29378592","citation_count":53,"is_preprint":false},{"pmid":"20668334","id":"PMC_20668334","title":"Transcriptional regulation of an axonemal central apparatus gene, sperm-associated antigen 6, by a SRY-related high mobility group transcription factor, S-SOX5.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20668334","citation_count":53,"is_preprint":false},{"pmid":"37832549","id":"PMC_37832549","title":"Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation.","date":"2023","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/37832549","citation_count":51,"is_preprint":false},{"pmid":"30816573","id":"PMC_30816573","title":"miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30816573","citation_count":51,"is_preprint":false},{"pmid":"17485346","id":"PMC_17485346","title":"Transcriptional activation of cartilage oligomeric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP/p300 coactivators.","date":"2007","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/17485346","citation_count":51,"is_preprint":false},{"pmid":"24607904","id":"PMC_24607904","title":"Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24607904","citation_count":50,"is_preprint":false},{"pmid":"30551470","id":"PMC_30551470","title":"Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30551470","citation_count":49,"is_preprint":false},{"pmid":"17230535","id":"PMC_17230535","title":"Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.","date":"2007","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17230535","citation_count":47,"is_preprint":false},{"pmid":"12406576","id":"PMC_12406576","title":"Identification and characterization of the human long form of Sox5 (L-SOX5) gene.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12406576","citation_count":47,"is_preprint":false},{"pmid":"21262861","id":"PMC_21262861","title":"SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21262861","citation_count":46,"is_preprint":false},{"pmid":"24699463","id":"PMC_24699463","title":"Sox5 functions as a fate switch in medaka pigment cell development.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24699463","citation_count":45,"is_preprint":false},{"pmid":"29621239","id":"PMC_29621239","title":"Distinct interactions of Sox5 and Sox10 in fate specification of pigment cells in medaka and zebrafish.","date":"2018","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29621239","citation_count":45,"is_preprint":false},{"pmid":"31325096","id":"PMC_31325096","title":"Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.","date":"2019","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/31325096","citation_count":45,"is_preprint":false},{"pmid":"25572815","id":"PMC_25572815","title":"SOX5 promotes epithelial-mesenchymal transition and cell invasion via regulation of Twist1 in hepatocellular carcinoma.","date":"2015","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25572815","citation_count":44,"is_preprint":false},{"pmid":"31868949","id":"PMC_31868949","title":"NEAT1/miR-193a-3p/SOX5 axis regulates cartilage matrix degradation in human osteoarthritis.","date":"2020","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/31868949","citation_count":44,"is_preprint":false},{"pmid":"29731835","id":"PMC_29731835","title":"Effect of miR-146a-5p on proliferation and metastasis of triple-negative breast cancer via regulation of SOX5.","date":"2018","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29731835","citation_count":44,"is_preprint":false},{"pmid":"21401405","id":"PMC_21401405","title":"Electroporation-mediated transfer of SOX trio genes (SOX-5, SOX-6, and SOX-9) to enhance the chondrogenesis of mesenchymal stem cells.","date":"2011","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/21401405","citation_count":44,"is_preprint":false},{"pmid":"31917898","id":"PMC_31917898","title":"CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.","date":"2020","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31917898","citation_count":43,"is_preprint":false},{"pmid":"29706965","id":"PMC_29706965","title":"Transcription Factor SOX5 Promotes the Migration and Invasion of Fibroblast-Like Synoviocytes in Part by Regulating MMP-9 Expression in Collagen-Induced Arthritis.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29706965","citation_count":41,"is_preprint":false},{"pmid":"32329217","id":"PMC_32329217","title":"Activation of the SOX-5, SOX-6, and SOX-9 Trio of Transcription Factors Using a Gene-Activated Scaffold Stimulates Mesenchymal Stromal Cell Chondrogenesis and Inhibits Endochondral Ossification.","date":"2020","source":"Advanced healthcare materials","url":"https://pubmed.ncbi.nlm.nih.gov/32329217","citation_count":41,"is_preprint":false},{"pmid":"31147293","id":"PMC_31147293","title":"FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5.","date":"2019","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/31147293","citation_count":40,"is_preprint":false},{"pmid":"27347933","id":"PMC_27347933","title":"MicroRNA-21a-5p Functions on the Regulation of Melanogenesis by Targeting Sox5 in Mouse Skin Melanocytes.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27347933","citation_count":40,"is_preprint":false},{"pmid":"29895198","id":"PMC_29895198","title":"Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21/SOX5 pathway.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/29895198","citation_count":39,"is_preprint":false},{"pmid":"9710541","id":"PMC_9710541","title":"The energetics of HMG box interactions with DNA. Thermodynamic description of the box from mouse Sox-5.","date":"1998","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9710541","citation_count":38,"is_preprint":false},{"pmid":"25453832","id":"PMC_25453832","title":"Sox5 Is a DNA-binding cofactor for BMP R-Smads that directs target specificity during patterning of the early ectoderm.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/25453832","citation_count":36,"is_preprint":false},{"pmid":"23220431","id":"PMC_23220431","title":"Haploinsufficiency of SOX5, a member of the SOX (SRY-related HMG-box) family of transcription factors is a cause of intellectual disability.","date":"2012","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23220431","citation_count":36,"is_preprint":false},{"pmid":"26045173","id":"PMC_26045173","title":"Expressions of Sox9, Sox5, and Sox13 transcription factors in mice testis during postnatal development.","date":"2015","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26045173","citation_count":35,"is_preprint":false},{"pmid":"28687615","id":"PMC_28687615","title":"SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28687615","citation_count":33,"is_preprint":false},{"pmid":"30854049","id":"PMC_30854049","title":"SOX5 promotes breast cancer proliferation and invasion by transactivation of EZH2.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30854049","citation_count":32,"is_preprint":false},{"pmid":"31578471","id":"PMC_31578471","title":"Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency.","date":"2019","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31578471","citation_count":31,"is_preprint":false},{"pmid":"29424904","id":"PMC_29424904","title":"miR-212-3p reduced proliferation, and promoted apoptosis of fibroblast-like synoviocytes via down-regulating SOX5 in rheumatoid arthritis.","date":"2018","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29424904","citation_count":31,"is_preprint":false},{"pmid":"19219070","id":"PMC_19219070","title":"Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19219070","citation_count":31,"is_preprint":false},{"pmid":"19173284","id":"PMC_19173284","title":"DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer.","date":"2009","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19173284","citation_count":30,"is_preprint":false},{"pmid":"31918278","id":"PMC_31918278","title":"RETRACTED: LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31918278","citation_count":30,"is_preprint":false},{"pmid":"21173167","id":"PMC_21173167","title":"Evolutionarily conserved, growth plate zone-specific regulation of the matrilin-1 promoter: L-Sox5/Sox6 and Nfi factors bound near TATA finely tune activation by Sox9.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21173167","citation_count":29,"is_preprint":false},{"pmid":"27550416","id":"PMC_27550416","title":"Modulation of IL-6 induced RANKL expression in arthritic synovium by a transcription factor SOX5.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27550416","citation_count":29,"is_preprint":false},{"pmid":"28186563","id":"PMC_28186563","title":"Silencing of the Drosophila ortholog of SOX5 leads to abnormal neuronal development and behavioral impairment.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28186563","citation_count":29,"is_preprint":false},{"pmid":"29888108","id":"PMC_29888108","title":"SOX5 interacts with YAP1 to drive malignant potential of non-small cell lung cancer cells.","date":"2018","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29888108","citation_count":29,"is_preprint":false},{"pmid":"26111154","id":"PMC_26111154","title":"Exome sequencing expands the mechanism of SOX5-associated intellectual disability: A case presentation with review of sox-related disorders.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26111154","citation_count":29,"is_preprint":false},{"pmid":"26927636","id":"PMC_26927636","title":"SOX5 is involved in balanced MITF regulation in human melanoma cells.","date":"2016","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/26927636","citation_count":29,"is_preprint":false},{"pmid":"28585545","id":"PMC_28585545","title":"Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28585545","citation_count":28,"is_preprint":false},{"pmid":"30819403","id":"PMC_30819403","title":"SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30819403","citation_count":28,"is_preprint":false},{"pmid":"32216582","id":"PMC_32216582","title":"Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer.","date":"2020","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/32216582","citation_count":27,"is_preprint":false},{"pmid":"35483515","id":"PMC_35483515","title":"Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways.","date":"2022","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/35483515","citation_count":26,"is_preprint":false},{"pmid":"23696452","id":"PMC_23696452","title":"Silencing of the Drosophila ortholog of SOX5 in heart leads to cardiac dysfunction as detected by optical coherence tomography.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23696452","citation_count":26,"is_preprint":false},{"pmid":"26043835","id":"PMC_26043835","title":"Rearrangement of chromosome bands 12q14~15 causing HMGA2-SOX5 gene fusion and HMGA2 expression in extraskeletal osteochondroma.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26043835","citation_count":26,"is_preprint":false},{"pmid":"18543318","id":"PMC_18543318","title":"Generation of mice harboring a Sox5 conditional null allele.","date":"2008","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/18543318","citation_count":25,"is_preprint":false},{"pmid":"23498568","id":"PMC_23498568","title":"Deletion 12p12 involving SOX5 in two children with developmental delay and dysmorphic features.","date":"2013","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23498568","citation_count":23,"is_preprint":false},{"pmid":"33993197","id":"PMC_33993197","title":"A novel lncRNA SOX2OT promotes the malignancy of human colorectal cancer by interacting with miR-194-5p/SOX5 axis.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33993197","citation_count":22,"is_preprint":false},{"pmid":"33473108","id":"PMC_33473108","title":"SOX-5 activates a novel RORγt enhancer to facilitate experimental autoimmune encephalomyelitis by promoting Th17 cell differentiation.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33473108","citation_count":22,"is_preprint":false},{"pmid":"28005327","id":"PMC_28005327","title":"Construction of PLGA Nanoparticles Coated with Polycistronic SOX5, SOX6, and SOX9 Genes for Chondrogenesis of Human Mesenchymal Stem Cells.","date":"2017","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/28005327","citation_count":22,"is_preprint":false},{"pmid":"31713604","id":"PMC_31713604","title":"Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis.","date":"2020","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31713604","citation_count":21,"is_preprint":false},{"pmid":"31040690","id":"PMC_31040690","title":"SOX5 promotes cell invasion and metastasis via activation of Twist-mediated epithelial-mesenchymal transition in gastric cancer.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31040690","citation_count":21,"is_preprint":false},{"pmid":"32949698","id":"PMC_32949698","title":"Neuroprotective effects of SOX5 against ischemic stroke by regulating VEGF/PI3K/AKT pathway.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32949698","citation_count":20,"is_preprint":false},{"pmid":"37517381","id":"PMC_37517381","title":"17-DMAG ameliorates neuroinflammation and BBB disruption via SOX5 mediated PI3K/Akt pathway after intracerebral hemorrhage in rats.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37517381","citation_count":20,"is_preprint":false},{"pmid":"35975639","id":"PMC_35975639","title":"circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.","date":"2022","source":"Gut and liver","url":"https://pubmed.ncbi.nlm.nih.gov/35975639","citation_count":20,"is_preprint":false},{"pmid":"9714725","id":"PMC_9714725","title":"The mouse Sox5 gene encodes a protein containing the leucine zipper and the Q box.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9714725","citation_count":20,"is_preprint":false},{"pmid":"24945754","id":"PMC_24945754","title":"High levels of SOX5 decrease proliferative capacity of human B cells, but permit plasmablast differentiation.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24945754","citation_count":19,"is_preprint":false},{"pmid":"30254466","id":"PMC_30254466","title":"SOX5 induces lung adenocarcinoma angiogenesis by inducing the expression of VEGF through STAT3 signaling.","date":"2018","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30254466","citation_count":19,"is_preprint":false},{"pmid":"33824420","id":"PMC_33824420","title":"LncRNA UCC promotes epithelial-mesenchymal transition via the miR-143-3p/SOX5 axis in non-small-cell lung cancer.","date":"2021","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33824420","citation_count":19,"is_preprint":false},{"pmid":"29890823","id":"PMC_29890823","title":"TNF-α-Induced SOX5 Upregulation Is Involved in the Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Through KLF4 Signal Pathway.","date":"2018","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/29890823","citation_count":19,"is_preprint":false},{"pmid":"24648396","id":"PMC_24648396","title":"Association study between polymorphisms of PRMT6, PEX10, SOX5, and nonobstructive azoospermia in the Han Chinese population.","date":"2014","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/24648396","citation_count":19,"is_preprint":false},{"pmid":"25847113","id":"PMC_25847113","title":"A maternally inherited 16p13.11-p12.3 duplication concomitant with a de novo SOX5 deletion in a male patient with global developmental delay, disruptive and obsessive behaviors and minor dysmorphic features.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25847113","citation_count":19,"is_preprint":false},{"pmid":"11266597","id":"PMC_11266597","title":"Solution structure and backbone dynamics of the DNA-binding domain of mouse Sox-5.","date":"2001","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/11266597","citation_count":19,"is_preprint":false},{"pmid":"28365963","id":"PMC_28365963","title":"SOX5 promotes epithelial-mesenchymal transition in osteosarcoma via regulation of Snail.","date":"2017","source":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28365963","citation_count":19,"is_preprint":false},{"pmid":"35878746","id":"PMC_35878746","title":"N6-Methyladenosine-induced miR-143-3p promotes intervertebral disc degeneration by regulating SOX5.","date":"2022","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/35878746","citation_count":18,"is_preprint":false},{"pmid":"33751650","id":"PMC_33751650","title":"CircSEC24A promotes IL-1β-induced apoptosis and inflammation in chondrocytes by regulating miR-142-5p/SOX5 axis.","date":"2021","source":"Biotechnology and applied biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33751650","citation_count":18,"is_preprint":false},{"pmid":"28371600","id":"PMC_28371600","title":"HuR Stabilizes lnc-Sox5 mRNA to Promote Tongue Carcinogenesis.","date":"2017","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/28371600","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49591,"output_tokens":9093,"usd":0.142584},"stage2":{"model":"claude-opus-4-6","input_tokens":13073,"output_tokens":3991,"usd":0.24771},"total_usd":0.390294,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"Sox5 protein localizes to the nucleus of post-meiotic round spermatids in mouse testis and binds specifically to the sequence AACAAT with moderately high affinity (Kd ~10^-9 M), inducing a significant bend in the DNA characteristic of HMG box proteins.\",\n      \"method\": \"Indirect immunofluorescence, in vitro footprinting, gel retardation assays, circular dichroism spectroscopy, 2D NMR\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal in vitro biochemical methods (footprinting, EMSA, CD, NMR) in a single study\",\n      \"pmids\": [\"8078768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"L-Sox5 (long form of Sox5) contains a coiled-coil domain that mediates homodimerization and heterodimerization with Sox6; dimerization greatly increases efficiency of binding to DNA containing adjacent HMG sites. L-Sox5, Sox6, and Sox9 cooperatively activate Col2a1 expression through a 48 bp chondrocyte-specific enhancer containing HMG-like sites.\",\n      \"method\": \"Coiled-coil domain analysis, dimerization assays, DNA binding assays, reporter assays in 10T1/2 and MC615 cells, co-expression studies in mouse embryos\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution of cooperative DNA binding, functional enhancer validation, replicated across multiple systems\",\n      \"pmids\": [\"9755172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The Sox5 HMG box from mouse undergoes two-stage reversible unfolding corresponding to two structural sub-domains (minor wing: helix 3 + N-terminal strand; major wing: helices I and II), with the minor wing considerably unfolded at physiological temperature (37°C).\",\n      \"method\": \"Differential scanning calorimetry, fluorescence spectroscopy, NMR\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — calorimetric and NMR structural characterization, rigorous biophysical methods\",\n      \"pmids\": [\"9710541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The Sox5 HMG box binds its AACAAT target DNA with an association constant of ~4×10^7 M^-1 (ΔG = −40 to −48 kJ/mol), with binding thermodynamics characteristic of minor groove HMG box proteins including a large negative heat capacity change (~−2 kJ/K/mol) reflecting dehydration of the protein-DNA interface.\",\n      \"method\": \"Fluorescence titration, isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC)\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — rigorous quantitative thermodynamic characterization with multiple complementary methods\",\n      \"pmids\": [\"10588902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Sox5 (L-Sox5) and Sox6 are required for formation of cartilage in mouse embryos; double-null mutants (Sox5−/−/Sox6−/−) show severe skeletal malformations with failure of chondroblast differentiation, establishing Sox5 and Sox6 as redundant transcriptional regulators of chondrogenesis.\",\n      \"method\": \"Genetic knockout mouse models, in vivo skeletal analysis\",\n      \"journal\": \"Osteoarthritis and cartilage\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined cellular phenotype, replicated across labs\",\n      \"pmids\": [\"11680692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"NMR solution structure of the mouse Sox5 HMG box in free solution reveals a characteristic twisted L-shape with two wings (major wing: helices 1 and 2; minor wing: helix 3 with N-terminal segment), with significant backbone mobility in the minor wing that increases toward termini.\",\n      \"method\": \"Multidimensional NMR with 15N-labeled protein, 15N relaxation measurements\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure determination with backbone dynamics characterization\",\n      \"pmids\": [\"11266597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Sox9 is required upstream of Sox5 and Sox6 in chondrogenesis; conditional inactivation of Sox9 before mesenchymal condensations abolishes Sox5 and Sox6 expression, placing Sox9 upstream of Sox5/Sox6 in the chondrogenic transcriptional hierarchy.\",\n      \"method\": \"Cre/loxP conditional knockout in mouse embryos, in situ hybridization for Sox5/Sox6 expression\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis established by conditional KO with specific marker expression readout\",\n      \"pmids\": [\"12414734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Sox5 and Sox6 are required in the notochord for formation of the extracellular matrix sheath, notochord cell survival, and development of the nucleus pulposus; Sox5−/−/Sox6−/− mice lack notochord ECM sheath and downregulate Col2a1, aggrecan, and perlecan in notochord cells.\",\n      \"method\": \"Genetic double-knockout mouse model, in situ hybridization, immunohistochemistry, apoptosis assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific molecular and cellular phenotype readouts\",\n      \"pmids\": [\"12571105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The combination of SOX5, SOX6, and SOX9 (the SOX trio) is sufficient to induce chondrocyte differentiation in non-chondrogenic cell types including dermal fibroblasts, suppressing hypertrophic and osteogenic differentiation simultaneously.\",\n      \"method\": \"Embryonic stem cell reporter assay, primary mesenchymal stem cell differentiation, marker gene expression, proteoglycan matrix accumulation\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in multiple cell types with molecular marker validation\",\n      \"pmids\": [\"15529345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sox5 and Sox6, together with Sox9 and coactivators CBP/p300, activate transcription of the COMP (cartilage oligomeric matrix protein) gene; Sox9 binds directly to a 13-nucleotide element in the COMP promoter PRE, and Sox5/Sox6 cooperate with Sox9 and CBP/p300 for full activation.\",\n      \"method\": \"Reporter assays, gel shift assays, siRNA knockdown, EMSA\",\n      \"journal\": \"Frontiers in bioscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct binding and reporter assays, single lab\",\n      \"pmids\": [\"17485346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"L-Sox5 and Sox6 drive aggrecan (Agc1) gene expression by binding to three elements in a far-upstream enhancer, which cooperatively increases the efficiency of Sox9 binding to its own recognition site within the same enhancer, thereby potentiating Sox9-driven transcription.\",\n      \"method\": \"Transgenic mouse reporter assays, ChIP, EMSA, mutational analysis of enhancer elements\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding demonstrated, transgenic validation in vivo, mechanistic mutational analysis\",\n      \"pmids\": [\"18559420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The coactivator Tip60 physically associates with Sox9 and Sox5 (identified by yeast two-hybrid and confirmed by co-IP), and the Sox9-Tip60-DNA complex assembles on the Col2a1 enhancer; Tip60 enhances Sox9 transcriptional activity and acetylates Sox9 at K61, K253, and K398 residues.\",\n      \"method\": \"Yeast two-hybrid, Co-IP, gel shift assay, reporter assay, ChIP, subnuclear colocalization, siRNA knockdown in micromass cultures\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (yeast 2-hybrid, reciprocal Co-IP, ChIP, reporter assay, in vitro functional validation)\",\n      \"pmids\": [\"18390577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Sox5 modulates Sox10 activity in the melanocyte lineage by binding to regulatory regions of melanocytic Sox10 target genes and recruiting corepressors CtBP2 and HDAC1, directly inhibiting Sox10-dependent promoter activation; Sox5 loss partially rescues the melanoblast reduction in Sox10 heterozygous mice.\",\n      \"method\": \"Genetic mouse models (Sox5 KO, Sox10 het crosses), ChIP showing Sox5 recruitment of CtBP2 and HDAC1, reporter assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis, ChIP, reporter assays with mechanistic corepressor identification\",\n      \"pmids\": [\"18703590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"S-SOX5 (48-kDa short isoform) directly binds to and activates the SPAG6 (sperm-associated antigen 6) promoter via SOX5 binding sites, cooperating with FOXJ1 to stimulate SPAG6 expression; mutation of SOX5 binding sites abrogates promoter activation.\",\n      \"method\": \"Luciferase reporter assay with SOX5 binding site mutations, ChIP, EMSA, siRNA knockdown, SOX5 overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding shown by EMSA and ChIP, causal link by site mutagenesis and RNAi\",\n      \"pmids\": [\"20668334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SOX5 overexpression in chick neural progenitors causes premature cell cycle exit, while SOX5 knockdown extends the proliferative period and causes cell death in a dorsal interneuron population; SOX5 reduces WNT-beta-catenin signaling by triggering expression of the negative regulator Axin2.\",\n      \"method\": \"In ovo overexpression and knockdown, cell cycle analysis, reporter assay for WNT pathway activity\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with pathway readout, but single model system\",\n      \"pmids\": [\"20448664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Sox5 and Sox6 are required for proper synovial joint morphogenesis; complete Sox5/Sox6 double KO prevents joint interzone formation and cavitation, while chondrocyte-specific inactivation (Col2Cre) also blocks joint morphogenesis, establishing that Sox5/Sox6 chondrogenic function is essential for joint development.\",\n      \"method\": \"Complete and cell-type-specific conditional knockout using Cre/loxP (Sox5fl/fl6fl/fl with Col2Cre and Gdf5Cre drivers), histology, marker gene expression\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple Cre drivers, specific cellular and molecular phenotypes\",\n      \"pmids\": [\"20206616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"L-Sox5/Sox6 and Nfib proteins bind to conserved proximal elements in the Matn1 (matrilin-1) promoter and modulate Sox9 transactivation in a protein dose-dependent manner to restrict expression to specific growth plate zones.\",\n      \"method\": \"Transgenic mouse reporter assays, EMSA, mutational analysis, protein binding assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding and transgenic validation, mechanistic detail on cooperativity\",\n      \"pmids\": [\"21173167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SOX5 and SOX6 physically interact with SHOX (short stature homeobox gene) via the SHOX homeodomain and SOX6 HMG domain (confirmed by yeast two-hybrid and co-immunoprecipitation in human cells), and this interaction is required for cooperative activation of the aggrecan (Agc1) upstream enhancer; LWD-causing SHOX missense mutations disrupt this interaction.\",\n      \"method\": \"Yeast two-hybrid screen, Co-IP in human cells, immunohistochemistry in human fetal growth plates, reporter assays, domain mapping\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, domain mapping, functional validation with disease-causing mutations\",\n      \"pmids\": [\"21262861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Sox5 knockout mice exhibit abnormal lung development with a delay in maturation before the saccular stage (as early as E16.5) associated with decreased fibronectin expression, an ECM component critical for branching morphogenesis.\",\n      \"method\": \"Sox5−/− mouse histology and gene expression analysis\",\n      \"journal\": \"American journal of respiratory and critical care medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific molecular readout, single lab\",\n      \"pmids\": [\"21330457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"L-Sox5 and Sox6 enhance Sox9 homodimer-driven transcription of miR-140 by binding to an L-Sox5/Sox6/Sox9 response element in the pri-miR-140 proximal promoter, boosting Sox9's DNA-binding and/or transactivation ability as a homodimer.\",\n      \"method\": \"Reporter assays in vivo and in vitro, ChIP, DNA binding analysis with genetically modified mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding and functional assays with genetic mouse models, single lab\",\n      \"pmids\": [\"22547066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sox5 (novel Th17-specific isoform Sox5t) physically associates with c-Maf via the HMG domain of Sox5 and the DNA-binding domain of c-Maf; Sox5 and c-Maf cooperatively and directly activate the RORγt promoter in CD4+ T cells, acting as downstream targets of Stat3 and upstream inducers of RORγt to drive Th17 differentiation.\",\n      \"method\": \"Co-immunoprecipitation (domain mapping), ChIP on RORγt promoter, retroviral overexpression in Stat3-deficient and RORγt-deficient cells, T cell-specific Sox5 KO mice with EAE model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — physical interaction with domain mapping, ChIP, genetic epistasis using multiple KO backgrounds, in vivo disease model\",\n      \"pmids\": [\"25073789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sox5 directly transactivates Twist1 expression in breast cancer cells by binding to the Twist1 promoter (shown by ChIP); Sox5 depletion downregulates Twist1, reduces EMT markers (N-cadherin, Vimentin, Fibronectin 1), and upregulates E-cadherin.\",\n      \"method\": \"ChIP assay, luciferase reporter, siRNA knockdown, Western blot\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP and reporter assay establish direct binding, single lab\",\n      \"pmids\": [\"24607904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Sox5 functions as a DNA-binding cofactor for BMP R-Smads (Smad1/4) in Xenopus ectoderm; Sox5 physically interacts with BMP R-Smads and is essential for recruitment of Smad1/4 to BMP regulatory elements, thereby activating BMP target genes required for neural crest and epidermal patterning.\",\n      \"method\": \"Xenopus embryo overexpression/knockdown, Co-IP of Sox5 with BMP R-Smads, ChIP showing Smad1/4 recruitment to BMP regulatory elements, target gene expression analysis\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — physical interaction demonstrated, ChIP shows recruitment to regulatory elements, genetic loss-of-function with specific patterning phenotype\",\n      \"pmids\": [\"25453832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SOX9 and SOX5/SOX6 bind thousands of genomic sites genome-wide in chondrocytes, frequently co-occupying super-enhancers (SEs); SOX9 recognizes pairs of inverted SOX motifs while SOX6 favors pairs of tandem SOX motifs; together they co-activate nearly all cartilage-specific SEs to drive the chondrocyte differentiation program.\",\n      \"method\": \"Genome-wide ChIP-seq for SOX6 and SOX9 in RCS cells, motif analysis, SE analysis, in vivo validation of target gene expression\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide ChIP-seq with motif analysis, functional validation of target genes in vivo\",\n      \"pmids\": [\"26150426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sox5 and Sox6 transcription factors directly promote oligodendrocyte progenitor migration by activating PDGFRα expression, thereby maintaining responsiveness to PDGF-A as a migratory cue; they also cooperate with Sox9 and Sox10 to activate PDGFRα expression, in contrast to their antagonism of SoxE proteins on myelin genes.\",\n      \"method\": \"CNS-specific conditional Sox5/Sox6 double KO mice, migration assays, marker gene expression, functional rescue\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with specific cellular and molecular phenotype, single lab\",\n      \"pmids\": [\"26345464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SOX5 directly binds and activates the RANKL promoter in IL-6-stimulated rheumatoid synovial fibroblasts; ChIP shows ~3-fold enrichment of RANKL-specific DNA in anti-SOX5 immunoprecipitate after IL-6 treatment; knockdown of SOX5 reduces IL-6-mediated RANKL upregulation and bone erosion in CIA mice.\",\n      \"method\": \"ChIP, overexpression/knockdown studies, in vivo CIA mouse model with local SOX5 silencing, immunohistochemistry\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrates direct promoter binding, in vivo functional validation\",\n      \"pmids\": [\"27550416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Sox5 promotes EMT and prostate cancer metastasis as a master regulator of TGF-β-induced EMT; Smad3 binds to the Sox5 promoter and regulates its expression, and Sox5 in turn binds to the Twist1 promoter to activate Twist1, which initiates EMT.\",\n      \"method\": \"ChIP, luciferase reporter assay, siRNA knockdown, xenograft mouse model, Western blot\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP for direct promoter binding, epistasis defined by pathway, in vivo validation\",\n      \"pmids\": [\"29123266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SOX5 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by directly binding to and activating the MMP-9 promoter; ChIP confirms SOX5 binding to MMP-9 promoter and deletion of the SOX5 binding site abolishes promoter-driven transcription; SOX5 knockdown reduces MMP-9 expression and pannus invasion in CIA mice.\",\n      \"method\": \"ChIP, luciferase reporter with SOX5 binding site deletion, transwell assay, in vivo CIA mouse model\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP + site-specific deletion mutant + in vivo validation, multiple orthogonal approaches\",\n      \"pmids\": [\"29706965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Sox5 regulates beta-cell phenotype and insulin secretion; Sox5 knockdown reduces depolarization-evoked Ca2+-influx and β-cell exocytosis, while SOX5 overexpression reverses expression perturbations in a T2D mouse model and improves glucose-stimulated insulin secretion in human islets.\",\n      \"method\": \"Sox5 knockdown/overexpression in pancreatic islets, Ca2+ imaging, patch-clamp exocytosis measurements, gene expression profiling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss- and gain-of-function with specific electrophysiological and secretion readouts, validated in human islets\",\n      \"pmids\": [\"28585545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Sox5 can suppress PDGFB-induced glioma development in Ink4a-deficient cells by increasing p27(Kip1) levels and inducing cellular senescence; Sox5 overexpression reduces Akt activation and increases p27(Kip1), and inhibition of p27(Kip1) reverses Sox5-mediated effects on proliferation and senescence.\",\n      \"method\": \"Retroviral overexpression of Sox5 in primary brain cell cultures, glioma mouse model, Western blot for Akt and p27(Kip1), p27 inhibition rescue experiments\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with pathway dissection and rescue experiment, single lab\",\n      \"pmids\": [\"19219070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SOX5, SOX6, and SOX21 prevent oncogene-driven transformation of brain stem cells; elevated SOX5/6/21 promotes cell cycle exit upon oncogenic stress and prevents glioma-like tumor formation; restoring SOX5/6/21 in glioblastoma cells enables CDK inhibitor expression, decreases p53 protein turnover, and triggers cellular senescence and apoptosis.\",\n      \"method\": \"Genetic ablation (Sox5/6/21 triple KO), in vivo mouse brain tumor model, overexpression in human glioblastoma cells, cell cycle analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with tumor phenotype, mechanistic molecular readouts\",\n      \"pmids\": [\"28687615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SOX5 promotes breast cancer proliferation and invasion by directly binding to and transactivating the EZH2 promoter; ChIP-seq and quantitative ChIP confirm SOX5 binding, and the biological effect of SOX5 is dependent on EZH2 expression.\",\n      \"method\": \"ChIP-seq, quantitative ChIP, luciferase reporter assay, gain/loss-of-function studies with MTT, colony formation, invasion assays\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq and reporter assay, rescue experiment demonstrates EZH2 dependence\",\n      \"pmids\": [\"30854049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SOX5 interacts with YAP1 as a protein complex in NSCLC cells to drive malignant potential; SOX5 is preferentially expressed by cancer stem-like cells, and silencing YAP1 attenuates malignant processes consistent with SOX5 loss; SOX5 overexpression reverses YAP1 knockdown-mediated effects.\",\n      \"method\": \"Co-immunoprecipitation, gain/loss-of-function studies, xenograft model\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP, functional epistasis by rescue experiment\",\n      \"pmids\": [\"29888108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SOX5 directly activates the GLUT4 promoter and is regulated by the VEGFR2/AKT1/GSK3β signaling pathway in ovarian cancer cells; SOX5 overexpression rescues GLUT4 expression and glycolysis suppressed by apatinib.\",\n      \"method\": \"Dual-luciferase reporter assay for GLUT4 promoter, RNA-seq, Western blot, xenograft model\",\n      \"journal\": \"Cellular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reporter assay for direct promoter activation, pathway validation by rescue\",\n      \"pmids\": [\"31325096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FOX-A1 directly binds to the SOX5 promoter and transactivates SOX5 expression in lung adenocarcinoma, as demonstrated by ChIP-seq and ChIP assays; SOX5 is a downstream target of FOX-A1 driving EMT and chemoresistance.\",\n      \"method\": \"ChIP-seq, ChIP assay, qRT-PCR, Western blot, knockdown studies\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq identifies direct promoter occupancy, functional validation\",\n      \"pmids\": [\"31147293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SOX5 induces angiogenesis in lung adenocarcinoma by activating STAT3 phosphorylation and increasing VEGF expression; SOX5 overexpression promotes tube formation capacity of endothelial cells, and this is dependent on STAT3/VEGF signaling.\",\n      \"method\": \"Tube formation assay, lentiviral overexpression/knockdown, qRT-PCR, Western blot, tissue microarray\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional assay without direct promoter binding evidence for VEGF\",\n      \"pmids\": [\"30254466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Brachyury directly binds to two motifs in the SOX5 promoter (one canonical and one novel Bry-binding motif) and activates SOX5 transcription; SOX5 is a direct downstream target of Brachyury and mediates Brachyury-driven EMT and breast cancer bone metastasis.\",\n      \"method\": \"ChIP assay, luciferase reporter assay with binding motif identification, in vitro and in vivo metastasis assays\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP and reporter assay with novel motif identification, single lab\",\n      \"pmids\": [\"31713604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SOX5 transcriptionally activates VEGF expression to promote neuroprotection; SOX5 overexpression rescues LPS-induced apoptosis in PC-12 cells via VEGF-dependent PI3K/AKT pathway activation, as confirmed by ChIP-PCR and dual luciferase reporter assay.\",\n      \"method\": \"ChIP-PCR, dual luciferase reporter assay, Western blot, TUNEL assay, CCK-8 assay\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single ChIP and reporter assay, single cell model, single lab\",\n      \"pmids\": [\"32949698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SOX5 activates a novel RORγt enhancer (RORCE2) in Th17 cells by binding to its SOX5 binding site, which enables RORCE2 looping to the RORγt promoter and recruitment of STAT3 to the RORγt locus; RORCE2 deficiency suppresses RORγt expression and Th17 differentiation.\",\n      \"method\": \"CRISPR knockout of RORCE2, chromatin conformation capture (3C/looping assay), ChIP showing SOX5 and STAT3 binding, Th17 differentiation assays, EAE mouse model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO of enhancer, 3D chromatin looping, ChIP, in vivo disease model — multiple orthogonal methods\",\n      \"pmids\": [\"33473108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TNF-α upregulates SOX5 expression in human bone marrow mesenchymal stem cells, and SOX5 inhibits osteogenic differentiation through the KLF4 signaling pathway; SOX5 overexpression increases KLF4 expression, and KLF4 knockdown abrogates the inhibitory effect of SOX5 on osteogenesis.\",\n      \"method\": \"Overexpression/knockdown (RNA interference), ALP activity assay, RT-qPCR, Western blot, epistasis by KLF4 knockdown rescue\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — epistasis established by double knockdown rescue, single lab\",\n      \"pmids\": [\"29890823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SOX5 overexpression acts as a driver of cellular rejuvenation by binding to and elevating enhancer activity (H3K27ac and H3K4me1) of HMGB2, increasing HMGB2 expression; SOX5 gene therapy rejuvenates cartilage and alleviates osteoarthritis in aged mice.\",\n      \"method\": \"Genome-wide CRISPRa screening, epigenomic profiling (H3K27ac, H3K4me1 ChIP), SOX5 binding analysis, lentiviral gene therapy in aged mice\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide unbiased screen plus epigenomic validation of enhancer mechanism, in vivo validation\",\n      \"pmids\": [\"37832549\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SOX5 is a SRY-related HMG box transcription factor that functions primarily as a DNA-binding cofactor and transcriptional modulator: in chondrogenesis, L-Sox5 homodimerizes or heterodimerizes with Sox6 via a coiled-coil domain to cooperatively bind paired HMG sites on cartilage-specific enhancers (Col2a1, Agc1, COMP, Matn1, miR-140), potentiating Sox9-driven transcription genome-wide through super-enhancers; in immunity, a Th17-specific Sox5 isoform physically interacts with c-Maf and directly activates the RORγt promoter/enhancer downstream of STAT3 to drive Th17 differentiation; in cancer contexts, Sox5 directly transactivates Twist1, MMP-9, EZH2, RANKL, and VEGF promoters to promote EMT and invasion; and in neural and other lineages, Sox5 modulates SoxE protein (Sox9, Sox10) activity by competing for binding sites and recruiting corepressors (CtBP2, HDAC1), thereby acting as either a coactivator or repressor depending on cellular context.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SOX5 is an SRY-related HMG-box transcription factor that functions as a context-dependent transcriptional cofactor across chondrogenesis, immune differentiation, neural development, and cancer. In cartilage, the long isoform (L-Sox5) homodimerizes or heterodimerizes with Sox6 via a coiled-coil domain, binding paired HMG sites on enhancers of cartilage matrix genes (Col2a1, Agc1, COMP, Matn1, miR-140) to potentiate Sox9-driven transcription at super-enhancers genome-wide; Sox5/Sox6 double-knockout mice exhibit severe chondrodysplasia, failed joint morphogenesis, and notochord defects [PMID:9755172, PMID:18559420, PMID:26150426, PMID:11680692, PMID:12571105]. In Th17 cells, a lineage-specific isoform (Sox5t) physically interacts with c-Maf and activates a distal RORγt enhancer (RORCE2), enabling STAT3 recruitment and chromatin looping to the RORγt promoter to drive Th17 differentiation [PMID:25073789, PMID:33473108]. SOX5 can also repress SoxE-dependent transcription by recruiting CtBP2 and HDAC1 corepressors, as demonstrated in the melanocyte lineage where it inhibits Sox10 target genes, and it functions as a direct transcriptional activator of Twist1, EZH2, MMP-9, and VEGF in cancer contexts to promote epithelial–mesenchymal transition, invasion, and angiogenesis [PMID:18703590, PMID:24607904, PMID:30854049, PMID:29706965].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing the DNA-binding specificity and structural mode of Sox5: its HMG box binds the minor groove of AACAAT with nanomolar affinity and induces DNA bending, defining Sox5 as a canonical HMG-box transcription factor.\",\n      \"evidence\": \"In vitro footprinting, EMSA, CD, and 2D NMR on purified mouse Sox5 HMG box\",\n      \"pmids\": [\"8078768\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length protein binding properties unknown\", \"No cellular target genes identified\", \"In vivo relevance of AACAAT binding not tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Revealing how L-Sox5 achieves cooperative enhancer occupancy: its coiled-coil domain mediates homo- and heterodimerization with Sox6, enabling efficient binding to paired HMG sites and cooperative activation of the Col2a1 chondrocyte enhancer with Sox9.\",\n      \"evidence\": \"Dimerization assays, DNA-binding assays, and reporter assays in 10T1/2 and MC615 cells; biophysical characterization of HMG box unfolding by DSC and NMR\",\n      \"pmids\": [\"9755172\", \"9710541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide binding landscape unknown\", \"Structural basis of the Sox5–Sox6 coiled-coil interface unresolved\", \"Whether dimerization is required in vivo not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Genetic proof that Sox5 and Sox6 are essential, largely redundant regulators of chondrogenesis: double-null mice show catastrophic failure of chondroblast differentiation and skeletal formation, while single knockouts are viable.\",\n      \"evidence\": \"Sox5−/−/Sox6−/− double-knockout mouse embryos with in vivo skeletal analysis; NMR solution structure of free Sox5 HMG box confirmed L-shaped fold\",\n      \"pmids\": [\"11680692\", \"11266597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional targets not identified genome-wide\", \"Relative contribution of each gene in specific skeletal elements unclear\", \"Whether Sox5 has Sox6-independent roles not addressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing the transcriptional hierarchy: Sox9 is required upstream of Sox5/Sox6 expression, meaning Sox5/Sox6 act as Sox9-induced cofactors rather than independent initiators of chondrogenesis.\",\n      \"evidence\": \"Conditional Sox9 inactivation before mesenchymal condensation abolishes Sox5/Sox6 expression (Cre/loxP, in situ hybridization)\",\n      \"pmids\": [\"12414734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Sox9 directly activates Sox5 transcription or acts indirectly unknown\", \"Feedback from Sox5/Sox6 onto Sox9 not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Expanding Sox5/Sox6 function beyond cartilage: they are essential for notochord ECM sheath formation and nucleus pulposus development, with double knockouts lacking expression of Col2a1, aggrecan, and perlecan in notochord cells.\",\n      \"evidence\": \"Sox5−/−/Sox6−/− mice analyzed by in situ hybridization, immunohistochemistry, and apoptosis assays in notochord\",\n      \"pmids\": [\"12571105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of notochord cell death (apoptosis vs. anoikis) unclear\", \"Direct promoter occupancy in notochord not demonstrated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defining the enhancer-level mechanism: L-Sox5/Sox6 bind specific elements in the Agc1 far-upstream enhancer to cooperatively increase Sox9 binding efficiency, and Sox5 recruits the corepressors CtBP2 and HDAC1 on Sox10 target genes in melanocytes, establishing Sox5 as a dual-function cofactor (coactivator or corepressor depending on context).\",\n      \"evidence\": \"ChIP, EMSA, transgenic reporter assays for Agc1 enhancer; genetic epistasis (Sox5 KO × Sox10 het), ChIP for CtBP2/HDAC1 recruitment, and reporter assays for melanocyte genes; Tip60 interaction with Sox5/Sox9 on Col2a1 enhancer by yeast two-hybrid and Co-IP\",\n      \"pmids\": [\"18559420\", \"18703590\", \"18390577\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for cofactor switching unknown\", \"Whether CtBP2/HDAC1 recruitment occurs genome-wide or at select loci not determined\", \"How Sox5 discriminates between coactivator and corepressor modes unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Broadening Sox5 roles to sperm motility, neural development, and joint morphogenesis: S-Sox5 directly activates the SPAG6 promoter; Sox5 modulates WNT-β-catenin signaling in neural progenitors to control cell cycle exit; and Sox5/Sox6 are required for synovial joint interzone formation.\",\n      \"evidence\": \"ChIP/EMSA/site mutagenesis for SPAG6 promoter; in ovo overexpression/knockdown with WNT reporter in chick; Col2Cre and Gdf5Cre conditional double-KO mice for joint phenotype\",\n      \"pmids\": [\"20668334\", \"20448664\", \"20206616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether S-Sox5 has distinct target repertoire from L-Sox5 is unknown\", \"Direct Sox5 targets in neural progenitors not identified\", \"How Sox5/Sox6 regulate interzone specification molecularly unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying Sox5 as a key immune transcription factor: a Th17-specific isoform (Sox5t) interacts with c-Maf via the HMG domain and cooperatively activates the RORγt promoter downstream of STAT3, establishing Sox5 as essential for Th17 differentiation and autoimmune pathology.\",\n      \"evidence\": \"Co-IP with domain mapping, ChIP on RORγt promoter, T cell-specific Sox5 KO mice in EAE model, epistasis with Stat3-deficient and RORγt-deficient cells\",\n      \"pmids\": [\"25073789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide Sox5t targets in Th17 cells unknown\", \"Whether Sox5t has unique structural features vs. L-Sox5 not determined\", \"Role in human Th17-driven diseases not directly demonstrated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Sox5 acts as a cofactor for BMP R-Smads: it physically interacts with Smad1/4 and is required for their recruitment to BMP regulatory elements, activating BMP target genes for neural crest and epidermal patterning in Xenopus.\",\n      \"evidence\": \"Co-IP of Sox5 with BMP R-Smads, ChIP for Smad1/4 at BMP response elements, loss-of-function patterning phenotype in Xenopus embryos\",\n      \"pmids\": [\"25453832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conservation of Sox5–Smad interaction in mammals not tested\", \"Whether this applies to all BMP targets or a subset unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Genome-wide mapping reveals SOX9 and SOX5/SOX6 co-occupy thousands of sites including nearly all cartilage super-enhancers, with SOX6 preferring tandem SOX motifs and SOX9 inverted motifs, defining the chromatin logic of chondrocyte identity.\",\n      \"evidence\": \"ChIP-seq for SOX6 and SOX9 in RCS cells, motif enrichment analysis, super-enhancer identification\",\n      \"pmids\": [\"26150426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SOX5-specific ChIP-seq not performed (SOX6 used as proxy)\", \"3D chromatin architecture at these super-enhancers not mapped in chondrocytes\", \"Functional hierarchy among co-occupied enhancers unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Multiple studies establish Sox5 as a direct transcriptional activator in cancer and metabolic contexts: Sox5 binds the Twist1 promoter to drive EMT in breast and prostate cancer, activates MMP-9 in rheumatoid synoviocytes, and maintains β-cell identity and insulin secretion.\",\n      \"evidence\": \"ChIP and reporter assays for Twist1 and MMP-9 promoters; Sox5 knockdown/overexpression in pancreatic islets with Ca2+ imaging and exocytosis measurements; xenograft and CIA mouse models\",\n      \"pmids\": [\"24607904\", \"29123266\", \"29706965\", \"28585545\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Sox5 targets in β-cells not mapped genome-wide\", \"Whether EMT-driving function is isoform-specific unknown\", \"Mechanism of Sox5-mediated insulin exocytosis regulation unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The 3D chromatin mechanism of Sox5 in Th17 cells is elucidated: Sox5 binds a novel RORγt enhancer (RORCE2) to enable its looping to the RORγt promoter and STAT3 recruitment; CRISPR deletion of RORCE2 suppresses Th17 differentiation and ameliorates EAE.\",\n      \"evidence\": \"CRISPR knockout of RORCE2, 3C/chromatin looping assays, ChIP for SOX5 and STAT3, EAE model\",\n      \"pmids\": [\"33473108\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Sox5 establishes or maintains the loop is unknown\", \"Other Sox5-dependent enhancer loops in Th17 cells not identified\", \"RORCE2 conservation across species not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"SOX5 is identified as a driver of cellular rejuvenation: it binds and activates the HMGB2 enhancer (increasing H3K27ac and H3K4me1), and SOX5 gene therapy rejuvenates aged cartilage and alleviates osteoarthritis in mice.\",\n      \"evidence\": \"Genome-wide CRISPRa screen, epigenomic profiling (H3K27ac/H3K4me1 ChIP), SOX5 binding analysis, lentiviral gene therapy in aged mice\",\n      \"pmids\": [\"37832549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SOX5-mediated rejuvenation extends beyond cartilage unknown\", \"Mechanism by which HMGB2 mediates rejuvenation incompletely defined\", \"Long-term safety and durability of SOX5 gene therapy not assessed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for Sox5 isoform-specific partner selection (Sox6/c-Maf/Smad1/YAP1), the genome-wide Sox5 (as opposed to Sox6) cistrome in chondrocytes and Th17 cells, and how Sox5 switches between coactivator and corepressor modes across lineages.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No Sox5-specific ChIP-seq in primary chondrocytes\", \"Structural model of Sox5 coiled-coil dimer interface lacking\", \"Mechanism governing coactivator-to-corepressor switch unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 3, 10, 13, 23]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 10, 12, 13, 20, 21, 27, 31, 38, 40]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 10, 13, 20, 21, 23, 27, 31, 38, 40]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 6, 7, 8, 15, 22, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [20, 38]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [14, 22, 29]}\n    ],\n    \"complexes\": [\n      \"L-Sox5/Sox6 homodimer/heterodimer\",\n      \"Sox5/Sox6/Sox9 chondrogenic trio\"\n    ],\n    \"partners\": [\n      \"SOX6\",\n      \"SOX9\",\n      \"MAF\",\n      \"CTBP2\",\n      \"HDAC1\",\n      \"KAT5\",\n      \"SMAD1\",\n      \"YAP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}